Jun 2, 2026 08:02AM
Jun 2, 2026 08:00AM
Jun 1, 2026 06:59AM
Jun 1, 2026 06:59AM
Jun 1, 2026 06:56AM
Jun 1, 2026 06:55AM
May 29, 2026 08:02AM Bristol Myers Squibb drug reduces multiple myeloma progression risk by 52%
May 29, 2026 08:00AM
May 21, 2026 05:01PM
May 21, 2026 05:01PM
May 20, 2026 06:59AM
May 20, 2026 06:59AM
May 8, 2026 07:00AM
May 8, 2026 06:59AM Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib) for the Treatment of Active Psoriatic Arthritis in Adults
Apr 30, 2026 07:21AM
Apr 30, 2026 07:03AM
Apr 30, 2026 06:59AM
Apr 24, 2026 06:59AM
Apr 24, 2026 06:59AM
Apr 15, 2026 10:36AM
Apr 8, 2026 07:33AM Bristol-Myers Squibb (BMY) Reiterated at Neutral by Cantor Fitzgerald on Eliquis Outlook
Mar 30, 2026 04:21AM
Mar 29, 2026 11:45AM
Mar 29, 2026 11:45AM
Mar 28, 2026 07:00AM
Mar 23, 2026 06:59AM
Mar 20, 2026 04:42PM
Mar 20, 2026 04:42PM Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. and EMA Approvals for Opdivo® (nivolumab)
Mar 19, 2026 06:59AM
Mar 9, 2026 06:59AM
Mar 9, 2026 06:59AM
Mar 6, 2026 09:59PM
Mar 6, 2026 09:59PM
Feb 26, 2026 06:59AM
Feb 26, 2026 06:59AM SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously Treated Unresectable Locally Advanced or Metastatic Triple
Feb 23, 2026 08:29AM
Feb 23, 2026 06:59AM
Feb 23, 2026 06:59AM
Feb 20, 2026 07:58AM
Feb 17, 2026 07:00AM
Feb 17, 2026 06:59AM
Feb 10, 2026 07:44AM Bernstein Weighs In on Bristol-Myers Squibb (BMY) Ahead of H2 Critical Clinical Readouts
Feb 5, 2026 07:30AM
Feb 5, 2026 07:00AM
Feb 5, 2026 06:59AM
Jan 12, 2026 06:59AM
Jan 12, 2026 06:59AM
Jan 9, 2026 07:33AM
Dec 19, 2025 03:05PM Bristol Myers Squibb strikes deal with US government on drug pricing
Dec 19, 2025 03:05PM

1,198,737 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All